Skip to main content
Top

Cellular Oncology

Issue 4/2021

Content (16 Articles)

Open Access Gastric Cancer Review

Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer

Junling Chen, Minglin Zhang, Zhiyuan Ma, Dumin Yuan, Jiaxing Zhu, Biguang Tuo, Taolang Li, Xuemei Liu

Open Access Obesity Original paper

Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity

E. Benaiges, V. Ceperuelo-Mallafré, A. Madeira, R. Bosch, C. Núñez-Roa, M. Ejarque, E. Maymó-Masip, I. Huber-Ruano, M. Lejeune, J. Vendrell, S. Fernández-Veledo

Breast Cancer Original Article

Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

Niclas C. Blessin, Wenchao Li, Tim Mandelkow, Hannah L. Jansen, Cheng Yang, Jonas B. Raedler, Ronald Simon, Franziska Büscheck, David Dum, Andreas M. Luebke, Andrea Hinsch, Katharina Möller, Anne Menz, Christian Bernreuther, Patrick Lebok, Till Clauditz, Guido Sauter, Andreas Marx, Ria Uhlig, Waldemar Wilczak, Sarah Minner, Till Krech, Christoph Fraune, Doris Höflmayer, Eike Burandt, Stefan Steurer

Open Access Colchicine Original Article

Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers

Malene Bredahl Hansen, Maria Postol, Siri Tvingsholm, Inger Ødum Nielsen, Tiina Naumanen Dietrich, Pietri Puustinen, Kenji Maeda, Christoffel Dinant, Robert Strauss, David Egan, Marja Jäättelä, Tuula Kallunki

Open Access Hepatocellular Carcinoma Original Article

MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis

Ting Yu, Jiajian Yu, Lu Lu, Yize Zhang, Yadong Zhou, Yong Zhou, Fengling Huang, Lu Sun, Zhixian Guo, Guojun Hou, Zihui Dong, Bibo Wang

Cetuximab Original Article

Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells

Joana G. Rodrigues, Henrique O. Duarte, Catarina Gomes, Meritxell Balmaña, Álvaro M. Martins, Paul J. Hensbergen, Arnoud H. de Ru, Jorge Lima, André Albergaria, Peter A. van Veelen, Manfred Wuhrer, Joana Gomes, Celso A. Reis

Rhabdomyosarcoma Original Article

Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells

Shekoufeh Almasi, Tara E. Crawford Parks, Aymeric Ravel-Chapuis, Alex MacKenzie, Jocelyn Côté, Kyle N. Cowan, Bernard J. Jasmin

Addiction Original Article

CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer

Yafei Yang, Donggen Jiang, Ziyu Zhou, Haiyun Xiong, Xiangwei Yang, Guoyu Peng, Wuchao Xia, Shang Wang, Hanqi Lei, Jing Zhao, Zhirong Qian, Song Wu, Jun Pang

Glioblastoma Original Article

Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition

Deepak Babu, Anwita Mudiraj, Neera Yadav, Chandrashekhar Y.B.V.K., Manas Panigrahi, Phanithi Prakash Babu

Cholangiocarcinoma Original Article

The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma

Yuting Wang, Wen Zhang, Lin Chen, Wei Chen, Shufen Xu, Lingyu Tang, Yang Yang, Quanpeng Li, Qi Jiang, Lin Miao

Glioblastoma Original Article

A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing

Fan Fan, Hao Zhang, Ziyu Dai, Yakun Zhang, Zhiwei Xia, Hui Cao, Kui Yang, Shui Hu, Yong Guo, Fengqin Ding, Quan Cheng, Nan Zhang

Open Access Original Article

Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer

Reiri Shimazaki, Shigetsugu Takano, Mamoru Satoh, Mamoru Takada, Yoji Miyahara, Kosuke Sasaki, Hideyuki Yoshitomi, Shingo Kagawa, Katsunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Kazuyuki Sogawa, Shinichiro Motohashi, Fumio Nomura, Masaru Miyazaki, Masayuki Ohtsuka

Open Access Ovarian Cancer Short Communication

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry

Phyllis van der Ploeg, Laura A. M. van Lieshout, Anja van de Stolpe, Steven L. Bosch, Marjolein H. F. M. Lentjes-Beer, Ruud L. M. Bekkers, Jurgen M. J. Piek

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine